Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients (Q43751902)

26 November 2017

Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients (English)

1 reference

26 November 2017

Schüle C

1

1 reference

26 November 2017

Baghai T

2

1 reference

26 November 2017

Zwanzger P

3

1 reference

26 November 2017

Minov C

4

1 reference

26 November 2017

Padberg F

5

1 reference

26 November 2017

Rupprecht R

6

1 reference

26 November 2017

1 July 2001

1 reference

Journal of Psychiatric Research

26 November 2017

1 reference

26 November 2017

35

1 reference

26 November 2017

4

1 reference

26 November 2017

239-247

1 reference

Serial dexamethasone suppression tests in affective disorders

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Effect of interrupted sleep patterns and partial sleep deprivation on DST and mood in psychiatric house officers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Neuroendocrinological investigations during sleep deprivation in depression. II. Longitudinal measurement of thyrotropin, TH, cortisol, prolactin, GH, and LH during sleep and sleep deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Quantitative rating of depressive states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Effects of total sleep deprivation on urinary cortisol, self-rated arousal, and mood in depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Serial postdexamethasone cortisol levels in a patient undergoing ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The corticosteroid receptor hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Sustained antidepressive effect of repeated partial sleep deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Serial partial sleep deprivation in depression--clinical effects and dexamethasone suppression test results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment--neurobiological and psychometric assessment of course.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The dexamethasone suppression test and prediction of outcome in patients receiving ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

DST in healthy volunteers and after sleep deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Dexamethasone suppression test and sleep deprivation in endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Influence of sleep disruption and calorie restriction on biological markers for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Neuroendocrine measures in psychiatric patients: course and outcome with ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The dexamethasone suppression test as a monitor of clinical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The DST as a predictor of outcome in depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The dexamethasone suppression test in patients with mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Partial sleep deprivation as therapy for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Impact of sleep debt on metabolic and endocrine function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Circadian profiles of melatonin in melancholic depressed patients and healthy subjects in relation to cortisol secretion and sleep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Normalization of the dexamethasone suppression test at discharge from hospital. Its prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

Manipulations of sleep and phototherapy: nonpharmacological alternatives in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900027-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(01)00027-9

1 reference

26 November 2017

1 reference